Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Sylvia Annabel Dass, Rehasri Selva Rajan, Gee Jun Tye & Venugopal Balakrishnan. (2021) The potential applications of T cell receptor (TCR)-like antibody in cervical cancer immunotherapy. Human Vaccines & Immunotherapeutics 17:9, pages 2981-2994.
Read now
Read now
Angel Charles, Christopher M. Bourne, Tanya Korontsvit, Zita E. H. Aretz, Sung Soo Mun, Tao Dao, Martin G. Klatt & David A. Scheinberg. (2021) Low-dose CDK4/6 inhibitors induce presentation of pathway specific MHC ligands as potential targets for cancer immunotherapy. OncoImmunology 10:1.
Read now
Read now
Christian Jost, Diana Darowski, John Challier, Vesna Pulko, Lydia J Hanisch, Wei Xu, Ekkehard Mössner, Alexander Bujotzek, Stefan Klostermann, Pablo Umana, Roland E. Kontermann & Christian Klein. (2020) CAR-J cells for antibody discovery and lead optimization of TCR-like immunoglobulins. mAbs 12:1.
Read now
Read now
Devin B. Lowe, Camille K. Bivens, Alexis S. Mobley, Christian E. Herrera, Amanda L. McCormick, Timea Wichner, Manoj K. Sabnani, Laurence M. Wood & Jon A. Weidanz. (2017) TCR-like antibody drug conjugates mediate killing of tumor cells with low peptide/HLA targets. mAbs 9:4, pages 603-614.
Read now
Read now
Leonid Dubrovsky, Elliott Joseph Brea, Dmitry Pankov, Emily Casey, Tao Dao, Cheng Liu & David A. Scheinberg. (2016) Mechanisms of leukemia resistance to antibody dependent cellular cytotoxicity. OncoImmunology 5:9.
Read now
Read now
Articles from other publishers (24)
Even Walseng, Bo Wang, Chunning Yang, Pooja Patel, Chihao Zhao, Hanzhi Zhang, Peng Zhao & Yariv Mazor. (2023) Conformation-selective rather than avidity-based binding to tumor associated antigen derived peptide-MHC enables targeting of WT1-pMHC low expressing cancer cells by anti-WT1-pMHC/CD3 T cell engagers. Frontiers in Immunology 14.
Crossref
Crossref
Hardik Mody, Ken Ogasawara, Xu Zhu, Dale Miles, Prathap Nagaraja Shastri, Jochem Gokemeijer, Michael Z. Liao, Sreeneeranj Kasichayanula, Tong‐Yuan Yang, Nagendra Chemuturi, Swati Gupta, Vibha Jawa & Vijay V. Upreti. (2023) Best Practices and Considerations for Clinical Pharmacology and Pharmacometric Aspects for Optimal Development of CAR‐T and TCR‐T Cell Therapies: An Industry Perspective. Clinical Pharmacology & Therapeutics 114:3, pages 530-557.
Crossref
Crossref
Xinbo Yang, Daisuke Nishimiya, Sara Löchte, Kevin M. Jude, Marta Borowska, Christina S. Savvides, Michael Dougan, Leon Su, Xiang Zhao, Jacob Piehler & K. Christopher Garcia. (2023) Facile repurposing of peptide–MHC-restricted antibodies for cancer immunotherapy. Nature Biotechnology 41:7, pages 932-943.
Crossref
Crossref
Linghui Qian, Xuefen Lin, Xue Gao, Rizwan Ullah Khan, Jia-Yu Liao, Shubo Du, Jingyan Ge, Su Zeng & Shao Q. Yao. (2023) The Dawn of a New Era: Targeting the “Undruggables” with Antibody-Based Therapeutics. Chemical Reviews 123:12, pages 7782-7853.
Crossref
Crossref
Kathryn A. K. Finton, Peter B. Rupert, Della J. Friend, Ana Dinca, Erica S. Lovelace, Matthew Buerger, Domnita V. Rusnac, Ulysses Foote-McNabb, William Chour, James R. Heath, Jean S. Campbell, Robert H. Pierce & Roland K. Strong. (2023) Effects of HLA single chain trimer design on peptide presentation and stability. Frontiers in Immunology 14.
Crossref
Crossref
Sylvia Annabel Dass, Venugopal Balakrishnan, Norsyahida Arifin, Crystale Siew Ying Lim, Fazlina Nordin & Gee Jun Tye. (2022) The COVID-19/Tuberculosis Syndemic and Potential Antibody Therapy for TB Based on the Lessons Learnt From the Pandemic. Frontiers in Immunology 13.
Crossref
Crossref
Shijie Jin, Yanping Sun, Xiao Liang, Xinyu Gu, Jiangtao Ning, Yingchun Xu, Shuqing Chen & Liqiang Pan. (2022) Emerging new therapeutic antibody derivatives for cancer treatment. Signal Transduction and Targeted Therapy 7:1.
Crossref
Crossref
Xueyin Wang, Mark L. Sandberg, Aaron D. Martin, Kathleen R. Negri, Grant B. Gabrelow, Daniel P. Nampe, Ming-Lun Wu, Michele E. McElvain, Dora Toledo Warshaviak, Wen-Hua Lee, Julyun Oh, Mark E. Daris, Falene Chai, Christine Yao, James Furney, Craig Pigott, Alexander Kamb & Han Xu. (2021) Potent, Selective CARs as Potential T-Cell Therapeutics for HPV-positive Cancers. Journal of Immunotherapy 44:8, pages 292-306.
Crossref
Crossref
Xueyin Wang, Aaron D. Martin, Kathleen R. Negri, Michele E. McElvain, Julyun Oh, Ming-Lun Wu, Wen-Hua Lee, Yuta Ando, Grant B. Gabrelow, Dora Toledo Warshaviak, Mark L. Sandberg, Han Xu & Alexander Kamb. (2021) Extensive functional comparisons between chimeric antigen receptors and T cell receptors highlight fundamental similarities. Molecular Immunology 138, pages 137-149.
Crossref
Crossref
Vittoria Massafra, Sofia Tundo, Aline Dietzig, Axel Ducret, Christian Jost, Christian Klein, Roland E. Kontermann, Hendrik Knoetgen, Martin Steegmaier, Andrea Romagnani & Yvonne A. Nagel. (2021) Proteolysis-Targeting Chimeras Enhance T Cell Bispecific Antibody-Driven T Cell Activation and Effector Function through Increased MHC Class I Antigen Presentation in Cancer Cells. The Journal of Immunology 207:2, pages 493-504.
Crossref
Crossref
Aaron D. Martin, Xueyin Wang, Mark L. Sandberg, Kathleen R. Negri, Ming L. Wu, Dora Toledo Warshaviak, Grant B. Gabrelow, Michele E. McElvain, Bella Lee, Mark E. Daris, Han Xu & Alexander Kamb. (2021) Re-examination of MAGE-A3 as a T-cell Therapeutic Target. Journal of Immunotherapy 44:3, pages 95-105.
Crossref
Crossref
Guozhu Xie, Nikola A. Ivica, Bin Jia, Yingzhong Li, Han Dong, Yong Liang, Douglas Brown, Rizwan Romee & Jianzhu Chen. (2020) CAR-T cells targeting a nucleophosmin neoepitope exhibit potent specific activity in mouse models of acute myeloid leukaemia. Nature Biomedical Engineering 5:5, pages 399-413.
Crossref
Crossref
Han Xu, Agnes E. Hamburger, Jee-Young Mock, Xueyin Wang, Aaron D. Martin, Talar Tokatlian, Julyun Oh, Mark E. Daris, Kathleen R. Negri, Grant B. Gabrelow, Ming Lun Wu, Daniel P. Nampe, Grace E. Asuelime, Michele E. McElvain, Mark L. Sandberg & Alexander Kamb. (2020) Structure-function relationships of chimeric antigen receptors in acute T cell responses to antigen. Molecular Immunology 126, pages 56-64.
Crossref
Crossref
Monica L. Fernández-Quintero, Nancy D. Pomarici, Johannes R. Loeffler, Clarissa A. Seidler & Klaus R. Liedl. (2020) T-Cell Receptor CDR3 Loop Conformations in Solution Shift the Relative Vα-Vβ Domain Distributions. Frontiers in Immunology 11.
Crossref
Crossref
Jeong A. Park & Nai-Kong V. Cheung. (2020) Targets and Antibody Formats for Immunotherapy of Neuroblastoma. Journal of Clinical Oncology 38:16, pages 1836-1848.
Crossref
Crossref
Qinghua He, Zhaoyu Liu, Zhihua Liu, Yuxiong Lai, Xinke Zhou & Jinsheng Weng. (2019) TCR-like antibodies in cancer immunotherapy. Journal of Hematology & Oncology 12:1.
Crossref
Crossref
Wing Ki Wong, Jinwoo Leem & Charlotte M. Deane. (2019) Comparative Analysis of the CDR Loops of Antigen Receptors. Frontiers in Immunology 10.
Crossref
Crossref
Malgorzata Bobrowicz, Radoslaw Zagozdzon, Joanna Domagala, Roberta Vasconcelos-Berg, Emmanuella Guenova & Magdalena Winiarska. (2019) Monoclonal Antibodies in Dermatooncology—State of the Art and Future Perspectives. Cancers 11:10, pages 1420.
Crossref
Crossref
Yixiang Xu, Georgina To’a Salazar, Ningyan Zhang & Zhiqiang An. (2019) T-cell receptor mimic (TCRm) antibody therapeutics against intracellular proteins. Antibody Therapeutics 2:1, pages 22-32.
Crossref
Crossref
Markus W. Löffler, Daniel J. Kowalewski, Linus Backert, Jörg Bernhardt, Patrick Adam, Heiko Schuster, Florian Dengler, Daniel Backes, Hans-Georg Kopp, Stefan Beckert, Silvia Wagner, Ingmar Königsrainer, Oliver Kohlbacher, Lothar Kanz, Alfred Königsrainer, Hans-Georg Rammensee, Stefan Stevanović & Sebastian P. Haen. (2018) Mapping the HLA Ligandome of Colorectal Cancer Reveals an Imprint of Malignant Cell Transformation. Cancer Research 78:16, pages 4627-4641.
Crossref
Crossref
Mahiuddin Ahmed, Andres Lopez-Albaitero, Dmitry Pankov, Brian H. Santich, Hong Liu, Su Yan, Jingyi Xiang, Pei Wang, Aisha N. Hasan, Annamalai Selvakumar, Richard J. O’Reilly, Cheng Liu & Nai-Kong V. Cheung. (2018) TCR-mimic bispecific antibodies targeting LMP2A show potent activity against EBV malignancies. JCI Insight 3:4.
Crossref
Crossref
Daniel T. Harris, Marlies V. Hager, Sheena N. Smith, Qi Cai, Jennifer D. Stone, Philipp Kruger, Melissa Lever, Omer Dushek, Thomas M. Schmitt, Philip D. Greenberg & David M. Kranz. (2018) Comparison of T Cell Activities Mediated by Human TCRs and CARs That Use the Same Recognition Domains. The Journal of Immunology 200:3, pages 1088-1100.
Crossref
Crossref
Iva Trenevska, Demin Li & Alison H. Banham. (2017) Therapeutic Antibodies against Intracellular Tumor Antigens. Frontiers in Immunology 8.
Crossref
Crossref
Aaron Y. Chang, Tao Dao, Ron S. Gejman, Casey A. Jarvis, Andrew Scott, Leonid Dubrovsky, Melissa D. Mathias, Tatyana Korontsvit, Victoriya Zakhaleva, Michael Curcio, Ronald C. Hendrickson, Cheng Liu & David A. Scheinberg. (2017) A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens. Journal of Clinical Investigation 127:7, pages 2705-2718.
Crossref
Crossref